Millennium Management’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Millennium Management’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,514	Closed	-$8.64K	–	6691
2024 Q2	$8.64K	Buy	+11,514	New	+$7.37K	﹤0.01%	5625
2023 Q4	–	Sell	-1,621	Closed	-$4.83K	–	6811
2023 Q3	$4.83K	Buy	1,621 +313	+24%	+$571	﹤0.01%	5884
2023 Q2	$1.94K	Sell	1,308 -9,634	-88%	-$13.1K	﹤0.01%	5955
2023 Q1	$13K	Sell	10,942 -1,323	-11%	-$1.76K	﹤0.01%	5973
2022 Q4	$25K	Buy	+12,265	New	+$42.2K	﹤0.01%	5992
2021 Q4	–	Sell	-1,411	Closed	-$26K	–	7569
2021 Q3	$26K	Sell	1,411 -3,024	-68%	-$59.6K	﹤0.01%	6645
2021 Q2	$111K	Buy	+4,435	New	+$110K	﹤0.01%	6210

Other funds holding NVOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Millennium Management's NVOS Position: Q3 2024 in Review

Millennium Management sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q3 2024, closing a stake of 11,514 shares — an estimated $8.64K sold.

Millennium Management first reported a position in NVOS in Q2 2021 and held it in 7 quarters. The position peaked at $111K in Q2 2021. 16 funds tracked by Wall St. Rank hold NVOS as of Q3 2024.

Millennium Management reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Millennium Management sold 11,514 Novo Integrated Sciences, Inc. Common Stock shares in Q3 2024, an estimated $8.64K.
Millennium Management first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Millennium Management's Novo Integrated Sciences, Inc. Common Stock position peaked at $111K in Q2 2021.
16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.